跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIPTAZ MEDSURGE 2 g/0.25 g piperacillin (as sodium) 2 g / tazobactam (as sodium) 0.25 g powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PIPTAZ MEDSURGE 2 g/0.25 g piperacillin (as sodium) 2 g / tazobactam (as sodium) 0.25 g powder for injection vial
Approved
STANDARD
PIPTAZ MEDSURGE 2 g/0.25 g piperacillin (as sodium) 2 g / tazobactam (as sodium) 0.25 g powder for injection vial
Medsurge Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
cc698c984bee0523
Company
Medsurge Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
cc698c984bee0523
Product Name
PIPTAZ MEDSURGE 2 g/0.25 g piperacillin (as sodium) 2 g / tazobactam (as sodium) 0.25 g powder for injection vial
Artg Id
407018
Artg Name
PIPTAZ MEDSURGE 2 g/0.25 g piperacillin (as sodium) 2 g / tazobactam (as sodium) 0.25 g powder for injection vial
Sponsor
Medsurge Pharma Pty Ltd
Company Detail Path
/organization/medsurge-pharma-pty-ltd
Artg Date
2024-03-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
cc698c984bee0523
Type
Standard
Back to TGA Approvals